Sort by:
- Doctors (41)
London W1G 9LG
London W1G 8TL
London W1G 8TL
London W1G 8TL
Ali Mearza
Contact Info
Office Hours
- Today
- -
Ali Mearza
About Ali Mearza
One of the UK's top surgeons as voted by his peers, Mr Ali Mearza is a Director and Founding Partner at Ophthalmic Consultants of London. He is also the Clinical Director of Ophthalmology at Imperial College Healthcare NHS Trust, the UK's first Academic Health Sciences Centre. He specialises in cornea, cataract, laser and lens based vision correction techniques. He has over 30 peer reviewed publications and regularly presents at National & International meetings. His work has been featured in the media and on television and his You Tube channel has over 300,000 views to date.
Further information available via www.oclvision.com
Select Your Region
Latin America
References
1. Packer M. The Implantable Collamer Lens with a central port: review of the literature. Clin Ophthalmol. 2018;12:2427-2438.
2. Martínez-Plaza E, López-Miguel A, López-De La Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226: 117-125.
3. Packer M. Evaluation of the EVO/EVO+ Sphere and Toric Visian ICL: Six Month Results from the United States Food and Drug Administration Clinical Trial. Clin Ophthalmol. 2022;16:1541-53.
4. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016;10:1209-1215.
5. Zhang H, Deng Y, Ma K, Yin H, Tang J. Analysis on the changes of objective indicators of dry eye after implantable collamer lens (ICL) implantation surgery. Graefes Arch Clin Exp Ophthalmol. 2024 Jul;262(7):2321-2328.
6. Albo C, Nasser T, Szynkarski DT, Nguyen N, Mueller B, Libfraind L, Parkhurst G. A Comprehensive Retrospective Analysis of EVO/EVO+ Implantable Collamer Lens: Evaluating Refractive Outcomes in the Largest Single Center Study of ICL Patients in the United States. Clin Ophthalmol. 2024 Jan 9;18:69-78.